We caught up with Prof. Frank Sciurba (University of Pittsburgh, Pittsburgh, PA, USA) to discuss the 2 year findings from a US feasibility study of bronchial rheoplasty for chronic bronchitis and to learn more around the upcoming advances in chronic bronchitis.
The abstract ‘Bronchial Rheoplasty for Chronic Bronchitis: 2 Year Results from a Us Feasibility Study with Rheox®.‘ (Abstract number: P485) was presented at ATS 2022, 13-18 May 2022.
Questions
- What are the unmet needs in the management of people with chronic bronchitis?
- Could you give us a brief overview of the RheOX® system and its mechanism of action?
- Could you tell us a little about the feasibility study and its findings to date?
- What will be the next step in the clinical development of the RheOX® system?
- What are the hot topics and latest research you are looking forward to exploring in chronic bronchitis in 2022?
Disclosures: Frank Sciurba discloses receiving grant/ research support from Gala Therapeutics, Inc.
Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Victoria Jones.
Filmed in coverage of the ATS meeting 2022.
